{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:22:21Z","timestamp":1788168141551,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001625","name":"Foundation to Eradicate Duchenne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023507","name":"Cuban Research Institute","doi-asserted-by":"publisher","award":["U54HD090257"],"award-info":[{"award-number":["U54HD090257"]}],"id":[{"id":"10.13039\/100023507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50HD090254"],"award-info":[{"award-number":["P50HD090254"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["K99HL130035"],"award-info":[{"award-number":["K99HL130035"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R01HL153054"],"award-info":[{"award-number":["R01HL153054"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.isci.2023.107161","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T12:36:57Z","timestamp":1686919017000},"page":"107161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Vamorolone improves Becker muscular dystrophy and increases dystrophin protein in bmx model mice"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7454-3732","authenticated-orcid":false,"given":"Nikki M.","family":"McCormack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhu Y.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Tully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinitee","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson A.","family":"Fiorillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Heier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2023.107161_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.isci.2023.107161_bib2","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.isci.2023.107161_bib3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM198805263182104","article-title":"Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy","volume":"318","author":"Hoffman","year":"1988","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2023.107161_bib4","first-page":"98","article-title":"The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy","volume":"240","author":"Bushby","year":"1993","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.isci.2023.107161_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1399-0004.1976.tb00033.x","article-title":"Clinical studies in benign (Becker type) X-linked muscular dystrophy","volume":"10","author":"Emery","year":"1976","journal-title":"Clin. Genet."},{"key":"10.1016\/j.isci.2023.107161_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/archneur.1977.00500190042006","article-title":"The spectrum of mild X-linked recessive muscular dystrophy","volume":"34","author":"Ringel","year":"1977","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.isci.2023.107161_bib7","first-page":"786","article-title":"Cardiac involvement in Becker muscular dystrophy","volume":"24","author":"Finsterer","year":"2008","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.isci.2023.107161_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000068446","article-title":"The heart in human dystrophinopathies","volume":"99","author":"Finsterer","year":"2003","journal-title":"Cardiology"},{"key":"10.1016\/j.isci.2023.107161_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2023.107161_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/mus.27011","article-title":"The CINRG Becker Natural History Study: Baseline characteristics","volume":"62","author":"Clemens","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.isci.2023.107161_bib11","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects","volume":"5","author":"Heier","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2023.107161_bib12","doi-asserted-by":"crossref","first-page":"e201800186","DOI":"10.26508\/lsa.201800186","article-title":"Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy","volume":"2","author":"Heier","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.isci.2023.107161_bib13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jamaneurol.2022.2480","article-title":"Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial","volume":"79","author":"Guglieri","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.isci.2023.107161_bib14","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.celrep.2015.07.066","article-title":"TNF-alpha-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy","volume":"12","author":"Fiorillo","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2023.107161_bib15","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/art.41215","article-title":"Muscle Weakness in Myositis: MicroRNA-Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies","volume":"72","author":"Kinder","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.isci.2023.107161_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1152\/physiolgenomics.00134.2017","article-title":"Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone","volume":"50","author":"Fiorillo","year":"2018","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.isci.2023.107161_bib17","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1038\/ctg.2016.49","article-title":"Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease","volume":"7","author":"Heier","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.isci.2023.107161_bib18","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/ibd\/izaa209","article-title":"Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease","volume":"26","author":"Batra","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.isci.2023.107161_bib19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/jcsm.13171","article-title":"The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47","volume":"14","author":"Heier","year":"2023","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.isci.2023.107161_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/humu.20722","article-title":"Integrated DNA, cDNA, and protein studies in Becker muscular dystrophy show high exception to the reading frame rule","volume":"29","author":"Kesari","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.isci.2023.107161_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCGENETICS.109.867242","article-title":"Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy","volume":"2","author":"Kaspar","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.isci.2023.107161_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2023.107161_bib23","doi-asserted-by":"crossref","first-page":"e2144178","DOI":"10.1001\/jamanetworkopen.2021.44178","article-title":"Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial","volume":"5","author":"Mah","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.isci.2023.107161_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(89)91367-6","article-title":"Distinction of Becker from limb-girdle muscular dystrophy by means of dystrophin cDNA probes","volume":"1","author":"Norman","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2023.107161_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0022-510X(83)90071-0","article-title":"Size and composition of the calf and quadriceps muscles in Duchenne muscular dystrophy. A tomographic and histochemical study","volume":"60","author":"Jones","year":"1983","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.isci.2023.107161_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2044-5040-4-10","article-title":"Myofiber branching rather than myofiber hyperplasia contributes to muscle hypertrophy in mdx mice","volume":"4","author":"Faber","year":"2014","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.isci.2023.107161_bib27","doi-asserted-by":"crossref","first-page":"e112477","DOI":"10.1371\/journal.pone.0112477","article-title":"Non-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficits","volume":"9","author":"Heier","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2023.107161_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.omtn.2016.11.009","article-title":"Systemic Antisense Therapeutics for Dystrophin and Myostatin Exon Splice Modulation Improve Muscle Pathology of Adult mdx Mice","volume":"6","author":"Lu-Nguyen","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.isci.2023.107161_bib29","first-page":"43","article-title":"Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study","volume":"236","author":"Cros","year":"1989","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.isci.2023.107161_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/practneurol-2017-001695","article-title":"Muscle hypertrophy and pseudohypertrophy","volume":"17","author":"Walters","year":"2017","journal-title":"Practical Neurol."},{"key":"10.1016\/j.isci.2023.107161_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.880010204","article-title":"Becker-type muscular dystrophy","volume":"1","author":"Bradley","year":"1978","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.isci.2023.107161_bib32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/adc.63.5.484","article-title":"Growth and endocrine function in steroid sensitive nephrotic syndrome","volume":"63","author":"Rees","year":"1988","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.isci.2023.107161_bib33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJM195604052541402","article-title":"Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children","volume":"254","author":"Blodgett","year":"1956","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2023.107161_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1203\/00006450-197507000-00005","article-title":"Growth and skeletal maturation in asthmatic children: effect of corticosteroid treatment","volume":"9","author":"Morris","year":"1975","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.isci.2023.107161_bib35","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.2022.4315","article-title":"Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial","volume":"327","author":"Guglieri","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2023.107161_bib36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/hum.2011.127","article-title":"Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy","volume":"23","author":"Verhaart","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.isci.2023.107161_bib37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.43.2.342","article-title":"Methylprednisolone selectively affects dystrophin expression in human muscle cultures","volume":"43","author":"Hardiman","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2023.107161_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022960118","article-title":"Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in\u00a0vitro","volume":"118","author":"Al Tanoury","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2023.107161_bib39","doi-asserted-by":"crossref","first-page":"e1622","DOI":"10.1212\/WNL.0000000000009244","article-title":"Modeling disease trajectory in Duchenne muscular dystrophy","volume":"94","author":"Rooney","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2023.107161_bib40","first-page":"2529","article-title":"Prednisone induces anxiety and glial cerebral changes in rats","volume":"28","author":"Gonzalez-Perez","year":"2001","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.isci.2023.107161_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4530(94)00069-7","article-title":"Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze","volume":"20","author":"Korte","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.isci.2023.107161_bib42","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/1440-1681.12417","article-title":"Co-administration of deflazacort and doxycycline: a potential pharmacotherapy for Duchenne muscular dystrophy","volume":"42","author":"Pereira","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.isci.2023.107161_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mus.20646","article-title":"Weekly oral prednisolone improves survival and strength in male mdx mice","volume":"35","author":"Keeling","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.isci.2023.107161_bib44","doi-asserted-by":"crossref","first-page":"e11220","DOI":"10.1371\/journal.pone.0011220","article-title":"Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy","volume":"5","author":"Guerron","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2023.107161_bib45","doi-asserted-by":"crossref","first-page":"e0182449","DOI":"10.1371\/journal.pone.0182449","article-title":"Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein","volume":"12","author":"M\u00e2ncio","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2023.107161_bib46","doi-asserted-by":"crossref","first-page":"15958","DOI":"10.1074\/jbc.270.27.15958","article-title":"Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake","volume":"270","author":"De Vos","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2023.107161_bib47","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1210\/en.2018-00147","article-title":"Glucocorticoid-Induced Metabolic Disturbances Are Exacerbated in Obese Male Mice","volume":"159","author":"Harvey","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.isci.2023.107161_bib48","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/0024-3205(89)90026-X","article-title":"Corticosterone's dual metabolic actions","volume":"45","author":"Devenport","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.isci.2023.107161_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/JOE-20-0579","article-title":"Ghrelin receptor signaling is not required for glucocorticoid-induced obesity in female mice","volume":"250","author":"Silver","year":"2021","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.isci.2023.107161_bib50","first-page":"e15292","article-title":"Chronic glucocorticoid exposure causes brown adipose tissue whitening, alters whole-body glucose metabolism and increases tissue uncoupling protein-1","volume":"10","author":"Bel","year":"2022","journal-title":"Phys. Rep."},{"key":"10.1016\/j.isci.2023.107161_bib51","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.celrep.2019.04.041","article-title":"Glucocorticoid-Induced Obesity Develops Independently of UCP1","volume":"27","author":"Luijten","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2023.107161_bib52","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2016.06.011","article-title":"Glucocorticoids Acutely Increase Brown Adipose Tissue Activity in Humans, Revealing Species-Specific Differences in UCP-1 Regulation","volume":"24","author":"Ramage","year":"2016","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2023.107161_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fcvm.2017.00027","article-title":"Humans and Mice Display Opposing Patterns of \"Browning\" Gene Expression in Visceral and Subcutaneous White Adipose Tissue Depots","volume":"4","author":"Zuriaga","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.isci.2023.107161_bib54","doi-asserted-by":"crossref","first-page":"E514","DOI":"10.1152\/ajpendo.00259.2022","article-title":"Activation of beta-adrenergic receptor signaling prevents glucocorticoid-induced obesity and adipose tissue dysfunction in male mice","volume":"324","author":"Gado","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2023.107161_bib55","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00125-019-4887-0","article-title":"Androgens sensitise mice to glucocorticoid-induced insulin resistance and fat accumulation","volume":"62","author":"Gasparini","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.isci.2023.107161_bib56","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/0024-3205(87)90121-4","article-title":"Genetically obese (ob\/ob) mice are hypersensitive to glucocorticoid stimulation of feeding but dramatically resist glucocorticoid-induced weight loss","volume":"40","author":"McGinnis","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.isci.2023.107161_bib57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/biomedicines8100420","article-title":"Obesity Augments Glucocorticoid-Dependent Muscle Atrophy in Male C57BL\/6J Mice","volume":"8","author":"Gunder","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2023.107161_bib58","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1212\/WNL.45.4.677","article-title":"Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei","volume":"45","author":"Pegoraro","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2023.107161_bib59","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0960-8966(91)90119-D","article-title":"Dystrophin abnormalities in polymyositis and dermatomyositis","volume":"1","author":"Sewry","year":"1991","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.isci.2023.107161_bib60","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/hmg\/5.12.1963","article-title":"The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies","volume":"5","author":"Vainzof","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2023.107161_bib61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0008-6363(03)00385-7","article-title":"Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction","volume":"59","author":"Yoshida","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.isci.2023.107161_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13395-018-0171-0","article-title":"MuscleJ: a high-content analysis method to study skeletal muscle with a new Fiji tool","volume":"8","author":"Mayeuf-Louchart","year":"2018","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.isci.2023.107161_bib63","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/bioinformatics\/btaa847","article-title":"Colour deconvolution: stain unmixing in histological imaging","volume":"37","author":"Landini","year":"2021","journal-title":"Bioinformatics"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223012385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223012385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:02:03Z","timestamp":1788166923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004223012385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2589004223012385"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2023.107161","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vamorolone improves Becker muscular dystrophy and increases dystrophin protein in bmx model mice","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2023.107161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"107161"}}